EICHORCondition: Mitral Valve Regurgitation · Sponsor: Abbott Medical Devices
To evaluate the safety and performance of the Tendyne™ Mitral Valve System when used as intended in a contemporary, real-world setting.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Kepler University Hospital | Linz, Austria | — |
| UZ Gasthuisberg | Leuven, Belgium | — |
| University Hospital Olomouc | Olomouc, Czechia | — |
| IKEM Prague | Prague, Czechia | — |
| Hospital AGEL Trinec-Podlesi | Třinec, Czechia | — |
| Bordeaux University Hospital | Bordeaux, France | — |
| CHRU de Lille | Lille, France | — |
| Lyon University Hospital | Lyon, France | — |
| Rennes University Hospital | Rennes, France | — |
| Clinique Pasteur | Toulouse, France | — |
| Heart and Diabetes Center NRW | Bad Oeynhausen, Germany | — |
| German Heart Center Berlin | Berlin, Germany | — |
+ 24 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04818502